About: A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection.
Creator	Alberici, Federico Bossini, Nicola Bove, Sergio Bracchi, Martina Costantino, Ester Delbarba, Elisa Econimo, Laura Gaggia, Paola Gaggiotti, Mario Maffei, Camilla Manenti, Chiara Movilli, Ezio Pola, Alessandra Possenti, Stefano Scolari, Francesco Valerio, Francesca Affatato, Stefania Terlizzi, Vincenzo Boni, Francesca Calcaterra, Eleonora Camerini, Corrado Cortinovis, Roberta Gallico, Agnese Guerini, Alice Lucca, Bernardo Mucchetti, Alberto Pezzini, Elena Piarulli, Paola Saccà, Chiara Zappa, Mattia Zubani, Roberto
Source	Elsevier; Medline; PMC
abstract	Abstract The SARS-CoV-2 epidemic is pressuring health care systems worldwide. Disease outcomes in certain subgroups of patients are still scarce, and data are needed. Therefore, we describe here the experience of four dialysis centers of the Brescia Renal COVID task force. During March 2020, within an overall population of 643 hemodialysis patients, SARS-CoV-2 RNA positivity was detected in 94 (15%). At disease diagnosis, 37 of the 94 (39%) patients (group 1) were managed on an outpatient basis whereas the remaining 57 (61%) (group 2) required hospitalization. Choices regarding management strategy were made based on disease severity. In group 1, 41% received antivirals and 76% hydroxychloroquine. Eight percent died and 5% developed acute respiratory distress syndrome (ARDS). In group 2, 79% received antivirals and 77% hydroxychloroquine. Forty two percent died and 79% developed ARDS. Overall mortality rate for the entire cohort was 29%. History of ischemic cardiac disease, fever, older age (over age 70) and dyspnea at presentation were associated with the risk of developing ARDS whereas fever, cough and a C-reactive protein higher than 50 mg/l at disease presentation were associated with the risk of death. Thus, in our population of hemodialysis patients with SARS-CoV-2 infection, we documented a wide range of disease severity. The risk of ARDS and death is significant for patients requiring hospital admission at disease diagnosis.
has issue date	2020-05-08(xsd:dateTime)
bibo:doi	10.1016/j.kint.2020.04.030
bibo:pmid	32437768
has license	els-covid
sha1sum (hex)	849007b889c400765a793516e5fc97a40b51481b
schema:url	https://doi.org/10.1016/j.kint.2020.04.030
resource representing a document's title	A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection.
has PubMed Central identifier	PMC7206428
has PubMed identifier	32437768
schema:publication	Kidney Int
resource representing a document's body	covid:849007b889c400765a793516e5fc97a40b51481b#body_text
is schema:about of	named entity 'antivirals' named entity 'age' named entity 'Therefore' named entity 'ARDS' named entity 'patients' named entity 'developed' named entity 'COVID' named entity 'infection' named entity 'SARS-CoV-2' named entity 'Task Force' named entity 'BASIS' named entity 'RENAL' named entity '643' covid:arg/849007b889c400765a793516e5fc97a40b51481b named entity 'C-reactive protein' named entity 'patients' named entity 'March' named entity 'died' named entity 'Renal' named entity 'population' named entity 'documented' named entity 'presentation' named entity 'presentation' named entity 'developed' named entity 'Disease' named entity 'group 1' named entity 'positivity' named entity 'cardiac disease' named entity 'worldwide' named entity 'detected' named entity 'task force' named entity 'antivirals' named entity 'Renal' named entity 'Brescia' named entity 'Brescia' named entity 'acute respiratory distress syndrome' named entity 'SARS-CoV-2' named entity 'outpatient' named entity 'ARDS' named entity 'infection' named entity 'ARDS' named entity 'ischemic' named entity 'SARS-CoV-2' named entity 'epidemic' named entity 'risk of death' named entity 'cough' named entity 'hydroxychloroquine' named entity 'fever' named entity 'SARS-CoV-2' named entity 'hydroxychloroquine' named entity 'antivirals'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software